Literature DB >> 2232926

Expanding Medicaid drug formulary coverage. Effects on utilization of related services.

C M Kozma1, C E Reeder, E W Lingle.   

Abstract

Effects on utilization and expenditures occurring concurrently with an expansion of coverage in the South Carolina Medicaid drug formulary were investigated. Data were collected for prescriptions, physician office visits, and outpatient and inpatient hospital visits. Data were evaluated for a cohort of 12,139 individuals who had at least one prescription claim and were continuously eligible for benefits during the two-year study. A repeated measures design was employed to control the differences between subjects. A multivariate analysis of variance was used to detect overall differences in utilization and expenditures. A priori comparisons of means were performed to detect changes in levels and rates of expenditures and utilization for each service. Increases were observed in the number of prescriptions, physician visits, and outpatient visits per person while the number of inpatient hospital admissions declined. Similarly, expenditures increased for all service areas except the inpatient hospital service. The proportion of variance explained by the formulary change was small in all service areas, but would be of practical significance because of the large number of Medicaid recipients affected. From a theoretical perspective, an association of a reduction in inpatient hospital use and expenditures following the elimination of drug formulary restrictions is particularly noteworthy. These findings support the thesis that medical care services should not be viewed in isolation but rather as a system of interrelated activities. Interventions in one portion of the system are mirrored by changes in utilization of other components. Frequently, private and public medical care programs are managed with organizationally distinct benefit budgets, which are controlled independently. In view of the results of this study, this organizational approach may lead to a suboptimal allocation of resources.

Entities:  

Mesh:

Year:  1990        PMID: 2232926     DOI: 10.1097/00005650-199010000-00010

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  13 in total

1.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

Review 2.  The effect of managed care on prescription drug costs and benefits.

Authors:  A Lyles; F B Palumbo
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

Review 3.  Economic impact of cost-containment strategies in third party programmes in the US. Part II.

Authors:  C M Kozma; R M Schulz; W M Dickson; J T Dye; E R Cox; D A Holdford; L Michael; W N Yates; T L Young
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

4.  Impact of consumer fees on drug utilisation.

Authors:  D G Smith; D M Kirking
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

5.  Pharmaceutical formulation and healthcare expenditures.

Authors:  D A Sclar; T L Skaer
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 6.  Noncompliance with antihypertensive therapy. Economic consequences.

Authors:  T L Skaer; D A Sclar; L M Robison
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

7.  Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending.

Authors:  Becky A Briesacher; Bruce Stuart; Xiaoqang Ren; Jalpa A Doshi; Marian V Wrobel
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

Review 8.  Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions.

Authors:  Sanjoy Roy; S Suresh Madhavan
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Drug prices and third party payment: do they influence medication selection?

Authors:  J E Hux; C D Naylor
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

10.  Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms.

Authors:  D W Raisch; L M Klaurens; C Hayden; I Malagon; G Pulliam; R Fass
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.